Loading...
XJPX
6678
Market cap83mUSD
Jul 10, Last price  
2,073.00JPY
1D
1.62%
1Q
-10.45%
Jan 2017
5.55%
IPO
87.89%
Name

Techno Medica Co Ltd

Chart & Performance

D1W1MN
XJPX:6678 chart
P/E
12.90
P/S
1.23
EPS
160.65
Div Yield, %
3.33%
Shrs. gr., 5y
-4.08%
Rev. gr., 5y
4.45%
Revenues
11.24b
+13.43%
5,905,514,0006,668,551,0006,730,946,0007,055,186,0007,559,455,0007,980,933,0008,151,194,0009,000,060,0009,145,139,0009,032,422,0008,457,237,9998,654,247,0009,332,420,0009,810,534,0009,040,115,0009,699,077,0009,367,586,00010,283,851,0009,905,864,00011,236,606,000
Net income
1.07b
+6.61%
751,645,000873,233,000846,212,000784,077,000933,526,0001,074,418,0001,243,745,0001,355,064,0001,429,133,0001,197,035,000458,128,0001,308,516,0001,098,100,0001,000,452,0001,153,260,0001,281,384,0001,150,733,0001,348,130,0001,004,583,0001,070,987,000
CFO
1.10b
+12.57%
386,059,000543,612,000124,427,000683,559,000744,795,000732,904,0001,282,501,0001,051,651,0001,729,324,0001,075,474,000695,462,0001,517,084,000704,255,0001,269,281,000825,412,0002,062,978,000887,240,0001,142,703,000977,535,0001,100,442,000
Dividend
Mar 30, 202668 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Techno Medica Co., Ltd. is a Japanese company that specializes in the entire lifecycle of in-vitro diagnostic analyzers, covering their research, development, manufacturing, distribution, and international trade. Their product portfolio includes automated systems for test tube preparation, urine aliquot, and RFID-based management solutions for both biological specimens and blood transfusions. The company also supplies a diverse range of analytical instruments for measuring blood gases, electrolytes, erythrocyte sedimentation rates, nutrient levels, sugar and acid content, and for performing urine chemistry tests. Furthermore, Techno Medica provides electronic medical charting systems, various pre-analytical devices, essential consumables, and comprehensive after-sales support. Established in 1987, the company's main office is located in Yokohama, Japan.
URL
https://www.technomedica.co.jp/t01/
IPO date
Sep 17, 2003
Employees
225
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT